ACO Name and Location:
MHC Accountable Care Organization, LLC
5183 U.S. Route 60 East
Huntington, WV 25705
ACO Primary Contact:
David Campbell, Executive Director
Phone: (304) 399-4691
Email: [email protected]
|ACO Participants||ACO Participant in Joint Venture (Y-Yes; N-No)|
|UNIVERSITY PHYSICIANS & SURGEONS, INC. DBA MARSHALL HEALTH||N|
|ULTIMATE HEALTH SERVICES INC., DBA HUNTINGTON INTERNAL MEDICINE GROUP||N|
|CABELL HUNTINGTON HOSPITAL INC||N|
Members of the MHC ACO governing body:
|Member||Member's Voting Power||Membership Type||ACO Participant TIN Legal Business Name/DBA, if Applicable|
|Last Name||First Name||Title/Position|
|Bagby||Carolyn||Board Member||Voting Member (1)||Medicare Beneficiary Representative||N/A|
|Dial||Dr. Larry||Board Member, Vice-Chairperson||Voting Member (1)||ACO Participant Representative||University Physicians and Surgeons, Inc. dba Marshall Health|
|Fowler||Kevin||Board Member, Chairperson||Voting Member (1)||ACO Participant Representative||Cabell Huntington Hospital, Inc.|
|Morgan||Mark||Board Member, Secretary/Treasurer||Voting Member (1)||ACO Participant Representative||Ultimate Health Services, Inc. dba Huntington Internal Medicine Group|
|Shapiro||Dr. Joseph||Board Member||Voting Member (1)||ACO Participant Representative||University Physicians and Surgeons, Inc. dba Marshall Health|
|Snavely||Dr. Daniel||Board Member||Voting Member (1)||ACO Participant Representative||Ultimate Health Services, Inc. dba Huntington Internal Medicine Group|
|Ward||Monte||Board Member||Voting Member (1)||ACO Participant Representative||Cabell Huntington Hospital, Inc.|
Key clinical and administrative leadership:
ACO Executive: David Campbell, JD, Executive Director
Medical Director: Larry Dial, MD
Compliance Official: Lauren Savory, JD
Quality Assurance/Improvement Officer: Daniel Snavely, MD
ACO committees and committee leadership:
Quality Improvement and Clinical Integration Committee: Daniel Snavely, MD, Chairperson
Finance, Risk and Compliance Management Committee: Mark Morgan and Monte Ward, Co-Chairpersons
Data and Technology Committee: Dennis Lee, Chairperson
Operations Committee: Beth Hammers, Chairperson.
Types of ACO participants or combinations of participants that formed the ACO:
ACO professionals in a group practice arrangement
Hospital employing ACO professionals
Shared Savings and Losses information: To be completed after the conclusion of the performance year.
Shared Savings Distributions: To be completed after the conclusion of the performance year.
Use of payment rule waivers: No, MHC Accountable Care Organization, LLC does not utilize the SNF 3-Day Rule Waiver.
ACO’s performance on quality measures: To be completed after the conclusion of the performance year.
MSSP Pre-Participation Waiver: The Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human Services’ Office of Inspector General have provided certain waivers of federal fraud and abuse laws in connection with the operation of accountable care organizations under the Medicare Shared Savings Program (“MSSP”).
The Board of Managers of MHC Accountable Care Organization, LLC (“MHC ACO”) has duly authorized the arrangement described below and made a bona fide determination that this arrangement is reasonably related to the purposes of the MSSP because the arrangement will promote accountability for the quality, cost and overall care for Medicare beneficiaries assigned to ACO and/or encourages investment in infrastructure and redesigned care processes for high quality and efficient service delivery for patients, including Medicare beneficiaries. By undertaking this arrangement, MHC ACO and its Participants have acted with the good faith intent to apply for participation in the MSSP starting in Performance Year (calendar year) 2018.
Initial Organizational Investments: Cabell Huntington Hospital, Inc., as one of three Participants and Members of MHC ACO, has allocated staff time and incurred consulting and website development fees relating to MHC ACO’s formation, preparation and submission of the MSSP application and initial operations since April 1, 2017 (the “Initial Organizational Investments”) and these Initial Organizational Investment costs have been incurred consistent with the purposes of the MSSP as they were necessary to form the legal entity, comply with regulatory requirements, complete the MSSP application, and engage providers in anticipation of MSSP participation.
MHC ACO will publicly disclose additional arrangements that qualify for MSSP waivers as they are authorized by its governing board on this website, in compliance with CMS’s public disclosure requirements.